Malaria is treated with antimalarial drugs and measures to control symptoms, including medications to control fever, antiseizure medications when needed, fluids and electrolytes. Contact Us. Vaccination is expected to become an important tool to prevent malaria in the future. You may be more at risk from side effects if you: have HIV or AIDS have… Read More: Can you recover from malaria without treatment »
Print this page KENILWORTH, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC) that is not curable by… Read More: FDA Approves Merck’s Keytruda (pembrolizumab) for the Treatment of Patients… »
A new study finds a lower risk of adverse post-treatment outcomes among returning military service personnel with chronic pain who received nondrug therapy. Share on PinterestNew research shows that some nondrug therapies, including exercise therapy, can help relieve pain in veterans. Many people returning from military deployment experience physical and mental health issues. These can… Read More: Veterans benefit from pain treatment without drugs »
MONDAY, May 18, 2020 — The U.S. Food and Drug Administration approved Qinlock (ripretinib) tablets as a fourth-line treatment for adults with advanced gastrointestinal stromal tumors (GISTs), the agency announced Friday. The approval follows four other FDA-approved target therapies for GIST, including imatinib in 2002, sunitinib in 2006, regorafenib in 2013, and avapritinib in January.… Read More: Qinlock (Ripretinib) Approved as Fourth-Line Treatment for GIST »